000 01783 a2200505 4500
005 20250516145651.0
264 0 _c20140110
008 201401s 0 0 eng d
022 _a1471-2407
024 7 _a10.1186/1471-2407-13-215
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMüller, Berit Maria
245 0 0 _aDifferential expression of histone deacetylases HDAC1, 2 and 3 in human breast cancer--overexpression of HDAC2 and HDAC3 is associated with clinicopathological indicators of disease progression.
_h[electronic resource]
260 _bBMC cancer
_cApr 2013
300 _a215 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aBreast Neoplasms
_xenzymology
650 0 4 _aCarcinoma, Ductal, Breast
_xenzymology
650 0 4 _aCarcinoma, Lobular
_xenzymology
650 0 4 _aDisease Progression
650 0 4 _aFemale
650 0 4 _aHistone Deacetylase 1
_xmetabolism
650 0 4 _aHistone Deacetylase 2
_xmetabolism
650 0 4 _aHistone Deacetylases
_xmetabolism
650 0 4 _aHumans
650 0 4 _aKaplan-Meier Estimate
650 0 4 _aLymphatic Metastasis
650 0 4 _aMiddle Aged
650 0 4 _aNeoplasm Grading
650 0 4 _aReceptor, ErbB-2
_xmetabolism
650 0 4 _aReceptors, Estrogen
_xmetabolism
650 0 4 _aReceptors, Progesterone
_xmetabolism
650 0 4 _aTissue Array Analysis
700 1 _aJana, Lisa
700 1 _aKasajima, Atsuko
700 1 _aLehmann, Annika
700 1 _aPrinzler, Judith
700 1 _aBudczies, Jan
700 1 _aWinzer, Klaus-Jürgen
700 1 _aDietel, Manfred
700 1 _aWeichert, Wilko
700 1 _aDenkert, Carsten
773 0 _tBMC cancer
_gvol. 13
_gp. 215
856 4 0 _uhttps://doi.org/10.1186/1471-2407-13-215
_zAvailable from publisher's website
999 _c22708894
_d22708894